AR122079A1 - Composiciones y métodos para tratar la perdida auditiva asociada a kcnq4 - Google Patents
Composiciones y métodos para tratar la perdida auditiva asociada a kcnq4Info
- Publication number
- AR122079A1 AR122079A1 ARP210101314A ARP210101314A AR122079A1 AR 122079 A1 AR122079 A1 AR 122079A1 AR P210101314 A ARP210101314 A AR P210101314A AR P210101314 A ARP210101314 A AR P210101314A AR 122079 A1 AR122079 A1 AR 122079A1
- Authority
- AR
- Argentina
- Prior art keywords
- kcnq4
- compositions
- treating
- methods
- hearing loss
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
- C12N15/86—Viral vectors
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2750/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssDNA viruses
- C12N2750/00011—Details
- C12N2750/14011—Parvoviridae
- C12N2750/14111—Dependovirus, e.g. adenoassociated viruses
- C12N2750/14141—Use of virus, viral particle or viral elements as a vector
- C12N2750/14143—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Genetics & Genomics (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Zoology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biotechnology (AREA)
- General Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- General Health & Medical Sciences (AREA)
- Biophysics (AREA)
- Biochemistry (AREA)
- Wood Science & Technology (AREA)
- Biomedical Technology (AREA)
- Physics & Mathematics (AREA)
- Microbiology (AREA)
- Plant Pathology (AREA)
- Virology (AREA)
- Toxicology (AREA)
- Gastroenterology & Hepatology (AREA)
- Medicinal Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
La presente invención se refiere a tecnologías que comprenden un polinucleótido capaz de expresar y/o inhibir un producto génico de KCNQ4.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US202063024488P | 2020-05-13 | 2020-05-13 |
Publications (1)
Publication Number | Publication Date |
---|---|
AR122079A1 true AR122079A1 (es) | 2022-08-10 |
Family
ID=76584537
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ARP210101314A AR122079A1 (es) | 2020-05-13 | 2021-05-12 | Composiciones y métodos para tratar la perdida auditiva asociada a kcnq4 |
Country Status (5)
Country | Link |
---|---|
US (1) | US20230212606A1 (es) |
EP (1) | EP4165194A2 (es) |
AR (1) | AR122079A1 (es) |
TW (1) | TW202208406A (es) |
WO (1) | WO2021231538A2 (es) |
Family Cites Families (20)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0173552B1 (en) | 1984-08-24 | 1991-10-09 | The Upjohn Company | Recombinant dna compounds and the expression of polypeptides such as tpa |
US5168062A (en) | 1985-01-30 | 1992-12-01 | University Of Iowa Research Foundation | Transfer vectors and microorganisms containing human cytomegalovirus immediate-early promoter-regulatory DNA sequence |
US4797368A (en) | 1985-03-15 | 1989-01-10 | The United States Of America As Represented By The Department Of Health And Human Services | Adeno-associated virus as eukaryotic expression vector |
US5139941A (en) | 1985-10-31 | 1992-08-18 | University Of Florida Research Foundation, Inc. | AAV transduction vectors |
US5478745A (en) | 1992-12-04 | 1995-12-26 | University Of Pittsburgh | Recombinant viral vector system |
US6001650A (en) | 1995-08-03 | 1999-12-14 | Avigen, Inc. | High-efficiency wild-type-free AAV helper functions |
WO1998010088A1 (en) | 1996-09-06 | 1998-03-12 | Trustees Of The University Of Pennsylvania | An inducible method for production of recombinant adeno-associated viruses utilizing t7 polymerase |
US6156303A (en) | 1997-06-11 | 2000-12-05 | University Of Washington | Adeno-associated virus (AAV) isolates and AAV vectors derived therefrom |
EP1399183B1 (en) | 2001-05-31 | 2010-06-30 | Novartis Vaccines and Diagnostics, Inc. | Chimeric alphavirus replicon particles |
AU2002327614B2 (en) | 2001-09-06 | 2007-12-06 | Alphavax, Inc. | Alphavirus replicon vector systems |
NZ600121A (en) | 2001-11-13 | 2013-12-20 | Univ Pennsylvania | A method of detecting and/or identifying adeno-associated virus (aav) sequences and isolating novel sequences identified thereby |
DK2359869T3 (en) | 2001-12-17 | 2019-04-15 | Univ Pennsylvania | Sequences of adeno-associated virus (AAV) serotype 8, vectors containing these, and uses thereof |
SI2292780T1 (sl) | 2003-09-30 | 2017-12-29 | The Trustees Of The University Of Pennsylvania | Genotipske skupine, zaporedja, vektorji, ki vsebujejo le-te z adenovirusi povezanega virusa (aav) in njihova uporaba |
US7557197B2 (en) | 2004-01-28 | 2009-07-07 | Oregon Health & Science University | Human soluble neuropilin-1 primary polyadenylation signal and uses thereof |
US20060040354A1 (en) | 2004-07-20 | 2006-02-23 | O'keefe Theresa L | Novel polyadenylation signal for use in expression vectors |
ES2525143T3 (es) | 2005-04-07 | 2014-12-18 | The Trustees Of The University Of Pennsylvania | Cápsides de AAVrh.64 modificado, composiciones que las contienen y usos de las mismas |
EP1712641A1 (en) * | 2005-04-14 | 2006-10-18 | Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V. | Use of novel HNF4a target genes and their gene products |
EP2007795B1 (en) | 2006-03-30 | 2016-11-16 | The Board Of Trustees Of The Leland Stanford Junior University | Aav capsid proteins |
AU2013240248B2 (en) | 2012-03-26 | 2018-12-20 | The United States Of America, As Represented By The Secretary, Department Of Health And Human Services | Delivery of packaged RNA to mammalian cells |
WO2019173367A1 (en) * | 2018-03-05 | 2019-09-12 | Children's Medical Center Corporation | Compositions and methods for delivering nucleic acids to cochlear and vestibular cells |
-
2021
- 2021-05-12 WO PCT/US2021/031939 patent/WO2021231538A2/en unknown
- 2021-05-12 TW TW110117168A patent/TW202208406A/zh unknown
- 2021-05-12 US US17/923,636 patent/US20230212606A1/en active Pending
- 2021-05-12 EP EP21734251.8A patent/EP4165194A2/en active Pending
- 2021-05-12 AR ARP210101314A patent/AR122079A1/es unknown
Also Published As
Publication number | Publication date |
---|---|
EP4165194A2 (en) | 2023-04-19 |
WO2021231538A2 (en) | 2021-11-18 |
TW202208406A (zh) | 2022-03-01 |
WO2021231538A3 (en) | 2022-01-13 |
US20230212606A1 (en) | 2023-07-06 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CL2021002326A1 (es) | Composiciones de arni contra el angiotensinógeno (agt) y métodos para su uso (divisional de solicitud n° 202002865) | |
BR112018017086A2 (pt) | derivados de pirrolidina espiro-condensada como inibidores de enzimas desubiquitilantes (dub) | |
MX2018010427A (es) | Formas solidas de un inhibidor de tienopirimidindiona acetil coa carboxilasa y metodos para su produccion. | |
TN2017000125A1 (en) | Compositions and methods for inhibition of hao1 (hydroxyacid oxidase 1 (glycolate oxidase)) gene expression | |
BR112018013065A2 (pt) | composições e métodos para o tratamento de hemoglobinopatias | |
MX2018016057A (es) | Composiciones y metodos para tratar enfermedades cardiovasculares. | |
GB2530921A (en) | C1-INH compositions and methods for the prevention and treatment of disorders associated with C1 esterase inhibitor deficency | |
WO2020021477A3 (en) | Compositions and methods for treating the eye | |
NI202100018A (es) | Moduladores de la expresión de pnpla3 | |
CO2017008129A2 (es) | Método para prevenir o tratar la pérdida de la audición | |
MX2022008775A (es) | Metodo para el tratamiento de la epilepsia. | |
MY201921A (en) | Agent for preventing or treating fat-associated diseases and/or inflammation | |
EP4285912A3 (en) | Compositions and methods for modulating ataxin 3 expression | |
MX2018013184A (es) | Composiciones de saponinas y extractos vegetales. | |
NI202000085A (es) | Moduladores de la expresión de apol1 | |
WO2020021480A3 (en) | Compositions and methods for treating the eye | |
CL2021001488A1 (es) | Transposasa de piggybac mutada | |
BR112017015528A2 (pt) | processo para produção de um implante e implante | |
WO2021158635A8 (en) | Anti-viral compositions and methods of use | |
BR112016025333A2 (pt) | agente, produto e uso | |
CO2021007006A2 (es) | Moduladores de la expresión de irf5 | |
MX2021006326A (es) | Inhibidores de pcna. | |
EP3801620A4 (en) | COMPOSITIONS AND METHODS FOR THE TREATMENT OF PANCREATITIS | |
WO2019022586A3 (ko) | 간암의 예방 또는 치료용 약학적 조성물 | |
AR122079A1 (es) | Composiciones y métodos para tratar la perdida auditiva asociada a kcnq4 |